British Salk

Health Minister Robert Turton announced that Britain has developed a modified Salk vaccine, which will be available this year for 250,000 to 500,000 children aged two to nine. Main difference from the U.S. anti-polio vaccine: substitution of the milder Brunhilde strain of Type I virus for the more virulent Mahoney strain, on the ground that if any live virus slips through, Brunhilde is less likely to cause serious paralysis.

This file is automatically generated by a robot program, so reader's discretion is required.